000 nab a22 7a 4500
999 _c16660
_d16660
003 PC16660
005 20211116133948.0
008 211116b xxu||||| |||| 00| 0 eng d
040 _cH12O
041 _aeng
100 _91883
_aUsátegui Corral, Alicia
_eInstituto de Investigación i+12
100 _91880
_aCriado Carrasco, Gabriel
_eInstituto de Investigación i+12
100 _91881
_aRey Cerros, Manuel José del
_eInstituto de Investigación i+12
100 _92671
_aFaré García, Regina
_eInstituto de Investigación i+12
100 _91010
_aPablos Álvarez, José Luis
_eReumatología
245 0 0 _aTopical vitamin D analogue calcipotriol reduces skin fibrosis in experimental scleroderma.
_h[artículo]
260 _bArchives of dermatological research,
_c2014
300 _a306(8):757-61.
500 _aFormato Vancouver: Usategui A, Criado G, Del Rey MJ, Faré R, Pablos JL. Topical vitamin D analogue calcipotriol reduces skin fibrosis in experimental scleroderma. Arch Dermatol Res. 2014 Oct;306(8):757-61.
501 _aPMID: 24788893
504 _aContiene 21 referencias
520 _aVitamin D analogues can reduce TGF-β pro-fibrotic signaling in dermal fibroblasts, but they may also induce a potentially pro-fibrotic thymic stromal lymphopoietin (TSLP)-dependent Th2 cytokine local response. We have analyzed the net effect of topical vitamin D analogue calcipotriol (CPT) on the cytokine profile and the development of fibrosis in experimental model of bleomycin-induced fibrosis. Mice were simultaneously treated with topical CPT or vehicle cream and skin fibrosis was measured by collagen deposition, Masson's trichrome staining and hydroxyproline content. Cytokine and TSLP gene expression was evaluated by quantitative RT-PCR. We showed that in bleomycin injected skin, CPT administration significantly enhanced TSLP and IL-13 gene expression, but did not modify the expression of other cytokines. Skin fibrosis and hydroxyproline content were significantly reduced in CPT compared to vehicle-treated mice. In normal skin, topical administration of CPT lacked a direct pro-fibrotic effect. Our results demonstrate that topical CPT superinduces the expression of the TSLP/IL-13 Th2 axis in fibrotic skin, but it has a net anti-fibrotic effect. These data support the therapeutic use of topical vitamin D analogues for skin fibrosis.
710 _9123
_aServicio de Reumatología
710 _9625
_aInstituto de Investigación imas12
856 _uhttp://pc-h12o-es.m-hdoct.a17.csinet.es/pdf/pc/1/pc16660.pdf
_ySolicitar documento
942 _2ddc
_cART
_n0